Clinical Trials Insight: 700055171

Trial Profile

Clinical Trials Insight: 700055171

Phase of Trial: Phase II

Latest Information Update: 23 Apr 2007

At a glance

  • Drugs Chiglitazar (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Chipscreen Biosciences
  • Most Recent Events

    • 23 Apr 2007 Positive results have been reported in a Chipscreen media release.
    • 23 Apr 2007 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top